Release Date: 17/05/16 08:27 Summary: Settlement agreement reached with Lind-RRS.AX Price Sensitive: Yes Download Document 79.86KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%